Approaches Beyond Classic CAR T-Cells – Module 2

Program Overview

Navigating the Frontier of Hematologic Malignancy Therapies (2 of 5 Modules)

This activity provides an overview of novel approaches to T-cell immunotherapy, particularly the development of “off-the-shelf” T-cell therapies in the management of lymphomas and other hematologic malignancies.

Credit Expired

Target Audience

Hematologists, oncologists, and other healthcare professionals involved in the diagnosis and treatment of patients with blood cancers.

Educational Objectives

Upon completion of this activity, participants should be better able to:

  • Identify potential T-cell immunotherapeutic strategies for the treatment of lymphomas and other hematologic malignancies

Activity Faculty

Heslop, Helen-Faculty Headshot-135x135

Helen E. Heslop, MD, DSc (Hon) (Chair)

Professor, Departments of Medicine and Pediatrics
Director, Center for Cell and Gene Therapy
Dan L. Duncan Chair
Interim Director, Dan L. Duncan Comprehensive Cancer Center
Baylor College of Medicine
Houston, TX


Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources